T‐cell development is initiated when CD34 + pluripotent stem cells or their immediate progeny
leave the bone marrow Co migrate to the thymus. Upon arrival in the thymus the stem cell …

Solid organ transplantation is the treatment of choice for various end-stage diseases, but
requires the continuous need for immunosuppression to prevent allograft rejection. This comes …

OBJECTIVE: Mesenchymal stem cells (MSC) have been implicated as playing an important
role in hematopoietic stem cell engraftment. We identified and characterized a new …

Donor lymphocyte infusion (DLI) into patients with a relapse of their leukemia or multiple
myeloma after allogeneic stem cell transplantation (alloSCT) has been shown to be a …

Bipotential T/natural killer (NK) progenitor cells are present in the human thymus. Despite
their bipotential capacity, these progenitors develop predominantly to T cells in the thymus. …

Graft-versus-host disease and graft rejection are major complications of allogeneic HLA-mismatched
stem cell transplantation or organ transplantation that are caused by alloreactive T …

Donor-derived T lymphocytes directed against minor histocompatibility antigens (mHags)
exclusively expressed on cells of the hematopoietic lineages can eliminate hematologic …

Adoptive transfer of T cell receptor (TCR)-transduced T cells may be an attractive strategy to
target both hematological malignancies and solid tumors. By introducing a TCR, large …

The transfer of T cell receptor (TCR) genes into patient T cells is a promising approach for
the treatment of both viral infections and cancer. Although efficient methods exist to identify …

Genetic engineering of T lymphocytes is an attractive strategy to specifically redirect T-cell
immunity toward viral infections and malignancies. We previously demonstrated redirected …